Skip to main content
. 2024 Mar 15;16(3):787–797. doi: 10.4251/wjgo.v16.i3.787

Figure 3.

Figure 3

Patatin like phospholipase domain containing 8 protein expression according to TNM stage and tumor location. A: Patients at stage I and stage II [n = 153 for patatin like phospholipase domain containing 8 (PNPLA8) low group; n = 200 for PNPLA8 high group]; B: Patients at stage III and stage IV (n = 178 for PNPLA8 low group; n = 220 for PNPLA8 high group); C: Patients with left-sided colon cancer (n = 92 for PNPLA8 low group; n = 108 for PNPLA8 high group); D: Patients with right-sided colon cancer (n = 97 for PNPLA8 low group; n = 112 for PNPLA8 high group); E: Patients with rectal cancer (n = 142 for PNPLA8 low group; n = 200 for PNPLA8 high group). The hazard ratio (HR), 95% confidence interval (95%CI), and log-rank P values are indicated in each panel. OS: Overall survival.